Fund HoldingsGENERAL ATLANTIC, L.P.

Total Portfolio Value
$3.52B
Total Bought
$798.92M
Total Sold
$787.49M
Net Transaction
+$11.43M
Filing Period:
Securities
SharesValue ($K)
Q2 2024
Q3 2024
Change
Q2 2024
Q3 2024
Weight (%)
Change
DLOCAL(DLO)063,906,695+63,906,6950511,25414.53%+511,254
ALIGNMENT HEALTHCARE(ALHC)60,993,32360,993,3230476,968720,94120.50%+243,973
CENTESSA PHARMACEUTICALS09,681,818+9,681,8180154,8124.40%+154,812
EUROPEAN WAX CENTER
CLASS A COM
013,110,492+13,110,492089,1512.53%+89,151
ROYALTY PHARMA(RPRX)01,500,000+1,500,000042,4351.21%+42,435
SQUARESPACE10,611,07310,611,0730462,961492,67214.01%+29,711
AKERO THERAPEUTICS5,233,9895,233,9890122,789150,1634.27%+27,374
BLEND LABS19,132,44019,132,440045,15371,7472.04%+26,594
XP, INC(XP)29,617,73329,617,7330520,976531,34215.11%+10,366
THIRD HARMONIC BIO2,958,7622,958,762038,46440,0911.14%+1,627
ACELYRIN2,889,6682,889,668012,74314,2460.41%+1,503
GROVE COLLABORATIVE0936,020+936,02001,2640.04%+1,264
ALKAMI(ALKT)17,186,98515,520,318-1,666,667489,485489,51113.92%+25
WISH609,616609,61603,4813,3220.09%-158
ADAGENE264,000264,00008085860.02%-222
GROVE COLLABORATIVE936,0200-936,0201,6570-1,657
PHARVARIS
COM
7,531,2527,531,2520141,588139,4793.97%-2,109
IMMUNOCORE(IMCR)1,261,6841,261,684042,75839,2761.12%-3,482
RISKIFIED5,324,9985,324,998034,02725,1870.72%-8,839
OPENDOOR(OPEN)6,321,5190-6,321,51911,6320-11,632
ROYALTY PHARMA(RPRX)1,500,0000-1,500,00039,5550-39,555
CENTESSA PHARMACEUTICALS9,681,8180-9,681,81887,4270-87,427
EUROPEAN WAX CENTER
CLASS A COM
13,110,4920-13,110,492130,1870-130,187
DLOCAL(DLO)63,906,6950-63,906,695517,0050-517,005
Page 1 of 1